Psychotic Disorder — The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia
Citation(s)
Achalia RM, Chaturvedi SK, Desai G, Rao GN, Prakash O Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia. Asian J Psychiatr. 2014 Jun;9:31-5. doi: 10.1016/j.ajp.2013.12.010. Epub 2014 Jan 4.
Ben-Zeev D, Larson J, Sarratt M A possible role for Progressive Muscle Relaxation in the treatment of persecutory ideation. Med Hypotheses. 2010 Dec;75(6):568-71. doi: 10.1016/j.mehy.2010.07.033. Epub 2010 Aug 14.
Bernstein, D & Borkove, c. T. (1973). Progressive relaxation training. Champaign, IL: Research Press.
Bernstein, D A., & Borkovec, T. D. (1973). Progressive Relaxation Training: A Manual for the Helping Professions.
Chino B, Nemoto T, Fujii C, Mizuno M Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia. Psychiatry Clin Neurosci. 2009 Aug;63(4):521-8. doi: 10.1111/j.1440-1819.2009.01995.x. Epub 2009 Jun 15.
Erol A, Delibas H, Bora O, Mete L The impact of insight on social functioning in patients with schizophrenia. Int J Soc Psychiatry. 2015 Jun;61(4):379-85. doi: 10.1177/0020764014548287. Epub 2014 Sep 1.
Hartley S, Barrowclough C, Haddock G Anxiety and depression in psychosis: a systematic review of associations with positive psychotic symptoms. Acta Psychiatr Scand. 2013 Nov;128(5):327-46. doi: 10.1111/acps.12080. Epub 2013 Feb 4. Review.
Harvey PD, Loewenstein DA, Czaja SJ Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia. Neurobiol Dis. 2013 May;53:18-25. doi: 10.1016/j.nbd.2012.10.022. Epub 2012 Oct 31. Review.
Hedlund, J L. & Vieweg, B. W. (1980) The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. Journal of Operational Psychiatry, 11, 48- 65.
Hunter R, Barry S Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment. Eur Psychiatry. 2012 Aug;27(6):432-6. doi: 10.1016/j.eurpsy.2011.02.015. Epub 2011 May 23.
Marder SR, Galderisi S The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017 Feb;16(1):14-24. doi: 10.1002/wps.20385.
Mas-Expósito L, Amador-Campos JA, Gómez-Benito J, Lalucat-Jo L The World Health Organization Short Disability Assessment Schedule: a validation study in patients with schizophrenia. Compr Psychiatry. 2012 Feb;53(2):208-16. doi: 10.1016/j.comppsych.2011.0
McGrath J, Saha S, Chant D, Welham J Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67-76. doi: 10.1093/epirev/mxn001. Epub 2008 May 14. Review.
Müller DJ, Chowdhury NI, Zai CC The pharmacogenetics of antipsychotic-induced adverse events. Curr Opin Psychiatry. 2013 Mar;26(2):144-50. doi: 10.1097/YCO.0b013e32835dc9da. Review.
Oliveira SE, Carvalho H, Esteves F Toward an understanding of the quality of life construct: Validity and reliability of the WHOQOL-Bref in a psychiatric sample. Psychiatry Res. 2016 Oct 30;244:37-44. doi: 10.1016/j.psychres.2016.07.007. Epub 2016 Jul 8.
Overall, J E., 1974. The brief psychiatric rating scale in psychopharmacology research. In: Pichot, P., Olivier-Martin, E. (Eds.), Psychological Measurements in Psychopharmacology: Modern Problems in Psychopharmacology. Karger, Basel, Switzerland, pp. 67e78.
Overall, J E., Gorham, D.R., 1962. The brief psychiatric rating scale. Psychol. Rep. 10, 799e812.
Pallanti S, Quercioli L, Hollander E Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry. 2004 Jan;161(1):53-8.
Wang FZ, Luo D, Kanb W, Wang Y Combined intervention with education and progressive muscle relaxation on quality of life, functional disability, and positive symptoms in patients with acute schizophrenia. J Altern Complement Med. 2015 Mar;21(3):159-65. d
The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia: Randomized Controlled Trials
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.